Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of $17.16 billion as of June 26, 2025. Its market cap has decreased by -2.84% in one year.

Market Cap

17.16B

Enterprise Value

22.34B

Revenue

12.77B

Ranking

n/a

PE Ratio

50.63

Stock Price

$9.56

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.16B, an increase of 146.44%. That is a compound annual growth rate of 2.73%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2025	17.00B	-2.73%
Dec 30, 2024	17.48B	-18.50%
Dec 29, 2023	21.44B	-22.67%
Dec 30, 2022	27.73B	-7.87%
Dec 30, 2021	30.10B	5.02%
Dec 30, 2020	28.66B	-10.92%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	801.20M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	446.28M
CytoDyn	386.66M
Glass House Brands	378.93M

Market Cap Rankings